Loading...
Phase 2 randomized high-risK metachroNous oligometastatIc prostate cancer with hiGh-risk mutations treated witH meTastasiS directed therapy and niraparib/abiraterone acetate plus prednisone (KNIGHTS) trial.
Radwan, Noura Deek, Matthew Shi, Xiaolei Eggleston, Caitlin Baker, Kaysee Rana, Zaker Ferris, Matthew Kwok, Young Bentzen, Søren M. Ennis, Ronald
Radwan, Noura
Deek, Matthew
Shi, Xiaolei
Eggleston, Caitlin
Baker, Kaysee
Rana, Zaker
Ferris, Matthew
Kwok, Young
Bentzen, Søren M.
Ennis, Ronald
Author
Radwan, Noura
Deek, Matthew
Shi, Xiaolei
Eggleston, Caitlin
Baker, Kaysee
Rana, Zaker
Ferris, Matthew
Kwok, Young
Bentzen, Søren M.
Ennis, Ronald
Hathout, Lara
Saraiya, Biren
Mayer, Tina
Mannuel, Heather
Hussain, Arif, M.D.
Abramowitz, Matthew
Berlin, Alejandro
Mishra, Mark
Tran, Phuoc T.
Molitoris, Jason
Deek, Matthew
Shi, Xiaolei
Eggleston, Caitlin
Baker, Kaysee
Rana, Zaker
Ferris, Matthew
Kwok, Young
Bentzen, Søren M.
Ennis, Ronald
Hathout, Lara
Saraiya, Biren
Mayer, Tina
Mannuel, Heather
Hussain, Arif, M.D.
Abramowitz, Matthew
Berlin, Alejandro
Mishra, Mark
Tran, Phuoc T.
Molitoris, Jason
Advisor
Date
2025-03-28
Embargo until
Language
Book title
Journal
Publisher
Peer Reviewed
Type
Poster/Presentation
Research Area
Jurisdiction
Collections
Other Titles
See at
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
3rd Annual Department of Radiation Oncology Research Symposium. March 28, 2025.
Series/Report No.
Sponsors
Rights/Terms
Attribution-NonCommercial-NoDerivatives 4.0 International